Literature DB >> 19369373

Fatty acid composition of plasma phospholipids and risk of prostate cancer.

Ching Kuang Chow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19369373     DOI： 10.3945/ajcn.2009.27682

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  10 in total

1.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Theodore M Brasky; Cathee Till; Emily White; Marian L Neuhouser; Xiaoling Song; Phyllis Goodman; Ian M Thompson; Irena B King; Demetrius Albanes; Alan R Kristal
Journal:  Am J Epidemiol       Date:  2011-04-24       Impact factor: 4.897

2.  Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda.

Authors:  Xiaoling Song; Pho Diep; Jeannette M Schenk; Corey Casper; Jackson Orem; Zeina Makhoul; Johanna W Lampe; Marian L Neuhouser
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-09-30       Impact factor: 4.006

3.  Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.

Authors:  Jian-Feng Qiu; Ke-Lin Zhang; Xiao-Jing Zhang; Yuan-Jia Hu; Peng Li; Chang-Zhen Shang; Jian-Bo Wan
Journal:  Lipids       Date:  2015-08-21       Impact factor: 1.880

4.  Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women.

Authors:  Kyoko Miura; Maria Celia B Hughes; Jacobus P J Ungerer; David D Smith; Adèle C Green
Journal:  Eur J Nutr       Date:  2016-12-19       Impact factor: 5.614

5.  Evaluation of the relationship between endometriosis and omega-3 and omega-6 polyunsaturated fatty acids.

Authors:  Korosh Khanaki; Mohammad Nouri; Ali M Ardekani; Alieh Ghassemzadeh; Vahideh Shahnazi; Mohammad R Sadeghi; Masoud Darabi; Amir Mehdizadeh; Homayon Dolatkhah; Abotaleb Saremi; Ali R Imani; Ali Rahimipour
Journal:  Iran Biomed J       Date:  2012

6.  Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Authors:  Theodore M Brasky; Amy K Darke; Xiaoling Song; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson; Frank L Meyskens; Gary E Goodman; Lori M Minasian; Howard L Parnes; Eric A Klein; Alan R Kristal
Journal:  J Natl Cancer Inst       Date:  2013-07-10       Impact factor: 13.506

7.  Measurement of Circulating Phospholipid Fatty Acids: Association between Relative Weight Percentage and Absolute Concentrations.

Authors:  Xiaoling Song; Jeannette M Schenk; Pho Diep; Rachel A Murphy; Tamara B Harris; Gudny Eiriksdottir; Vilmundur Gudnason; Corey Casper; Johanna W Lampe; Marian L Neuhouser
Journal:  J Am Coll Nutr       Date:  2016-06-17       Impact factor: 3.169

8.  Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices.

Authors:  Roel J T Mocking; Johanna Assies; Anja Lok; Henricus G Ruhé; Maarten W J Koeter; Ieke Visser; Claudi L H Bockting; Aart H Schene
Journal:  Lipids       Date:  2012-03-25       Impact factor: 1.880

9.  Structural equation modeling for analyzing erythrocyte fatty acids in Framingham.

Authors:  James V Pottala; Gemechis D Djira; Mark A Espeland; Jun Ye; Martin G Larson; William S Harris
Journal:  Comput Math Methods Med       Date:  2014-04-15       Impact factor: 2.238

10.  Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans.

Authors:  Susan Sergeant; Ingo Ruczinski; Priscilla Ivester; Tammy C Lee; Timothy M Morgan; Barbara J Nicklas; Rasika A Mathias; Floyd H Chilton
Journal:  Br J Nutr       Date:  2015-11-30       Impact factor: 3.718
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.